Genus (LON:GNS - Get Free Report) had its target price hoisted by research analysts at Deutsche Bank Aktiengesellschaft from GBX 2,250 ($30.20) to GBX 2,550 ($34.23) in a research report issued on Tuesday, Marketbeat.com reports. The brokerage currently has a "buy" rating on the stock. Deutsche Bank Aktiengesellschaft's target price would suggest a potential upside of 6.25% from the company's previous close.
Separately, Shore Capital reissued a "buy" rating and set a GBX 2,750 ($36.91) price target on shares of Genus in a research report on Tuesday.
Get Our Latest Stock Report on GNS
Genus Price Performance
Shares of GNS traded down GBX 20 ($0.27) during mid-day trading on Tuesday, hitting GBX 2,400 ($32.21). 126,212 shares of the company traded hands, compared to its average volume of 239,371. Genus has a one year low of GBX 1,424 ($19.11) and a one year high of GBX 2,485 ($33.36). The stock has a market capitalization of £1.57 billion, a price-to-earnings ratio of 198.94, a PEG ratio of 2.87 and a beta of 0.37. The company has a current ratio of 1.80, a quick ratio of 1.08 and a debt-to-equity ratio of 53.12. The business has a 50-day moving average of GBX 2,069.83 and a 200 day moving average of GBX 1,882.07.
Genus Company Profile
(
Get Free Report)
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Featured Stories
Before you consider Genus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.
While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
